YAP forms autocrine loops with the ERBB pathway to regulate ovarian cancer initiation and progression

Por He, Chunbo, Lv, Xiangmin, Hua, Guohua, Lele, Subodh M, Remmenga, Steven, Dong, Jixin, Davis, John S, Wang, Cheng
Publicado no Oncogene (2015)

Clinical potential of mucins in diagnosis, prognosis, and therapy of ovarian cancer

Por Singh, Ajay P, Senapati, Shantibhusan, Ponnusamy, Moorthy P, Jain, Maneesh, Lele, Subodh M, Davis, John S, Remmenga, Steven, Batra, Surinder K
Publicado no Lancet Oncol (2008)

G-1 inhibits breast cancer cell growth via targeting colchicine-binding site of tubulin to interfere with microtubule assembly

Por Lv, Xiangmin, He, Chunbo, Huang, Cong, Hua, Guohua, Wang, Zhengfeng, Remmenga, Steven W., Rodabough, Kerry J., Karpf, Adam R., Dong, Jixin, Davis, John S., Wang, Cheng
Publicado no Mol Cancer Ther (2017)

The Hippo/YAP pathway interacts with EGFR signaling and HPV oncoproteins to regulate cervical cancer progression

Por He, Chunbo, Mao, Dagan, Hua, Guohua, Lv, Xiangmin, Chen, Xingcheng, Angeletti, Peter C, Dong, Jixin, Remmenga, Steven W, Rodabaugh, Kerry J, Zhou, Jin, Lambert, Paul F, Yang, Peixin, Davis, John S, Wang, Cheng
Publicado no EMBO Mol Med (2015)

YAP Induces High-Grade Serous Carcinoma in Fallopian Tube Secretory Epithelial Cells

Por Hua, Guohua, Lv, Xiangmin, He, Chunbo, Remmenga, Steven W., Rodabough, Kerry J., Dong, Jixin, Yang, Liguo, Lele, Subodh M., Yang, Peixin, Zhou, Jin, Karst, Alison, Drapkin, Ronny I., Davis, John S., Wang, Cheng
Publicado no Oncogene (2015)